Stephen Mayo insider trades

Open-market stock purchases and sales by Stephen Mayo, Director at Allogene Therapeutics, Inc, from SEC Form 4 filings since Mar 15, 2021.

Recent trades

DateStockTradeValue
Jun 18, 2026ALLO Allogene Therapeutics, IncBought (not open market)—
Jun 4, 2026SRPT Sarepta Therapeutics, IncBought (not open market)—
May 29, 2026MRK Merck & Co, IncBought (not open market)$220K
Mar 12, 2026SRPT Sarepta Therapeutics, IncSold$123K

Companies traded

  • ALLO Allogene Therapeutics, Inc: 1 sale, last Jun 18, 2026
  • SRPT Sarepta Therapeutics, Inc: 3 sales, last Jun 4, 2026
  • MRK Merck & Co, Inc: other filings, last May 29, 2026

Get free alerts when Stephen Mayo files a new trade →